Werbung
Werbung

MIRA

MIRA logo

MIRA Pharmaceuticals, Inc. Common Stock

1.49
USD
Gesponsert
0.00
-0.34%
09. Jan., 15:56 UTC -5
Geschlossen
exchange

Nach-Markt

1.48

-0.01
-0.34%

MIRA Ergebnisberichte

Positives Überraschungsverhältnis

MIRA übertreffen die 5 der letzten 8Schätzungen.

63%

Nächster Bericht

Datum des nächsten Berichts
15. Apr. 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/
-$0.04
Implizierte Änderung von Q3 25 (Revenue/ EPS)
--
/
-33.33%
Implizierte Änderung von Q4 24 (Revenue/ EPS)
--
/
-73.33%

MIRA Pharmaceuticals, Inc. Common Stock earnings per share and revenue

On 13. Nov. 2025, MIRA reported earnings of -0.06 USD per share (EPS) for Q3 25, beating the estimate of -0.08 USD, resulting in a 26.47% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -6.29% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 3 analysts forecast an EPS of -0.04 USD, with revenue projected to reach -- USD, implying an decrease of -33.33% EPS, and increase of 0.00% in Revenue from the last quarter.
FAQ
For Q3 2025, MIRA Pharmaceuticals, Inc. Common Stock reported EPS of -$0.06, beating estimates by 26.47%, and revenue of $0.00, 0% as expectations.
The stock price moved down -6.29%, changed from $1.43 before the earnings release to $1.34 the day after.
The next earning report is scheduled for 15. Apr. 2026.
Based on 3 analysts, MIRA Pharmaceuticals, Inc. Common Stock is expected to report EPS of -$0.04 and revenue of -- for Q4 2025.
Scheck FXEmpire's Earnings Calendar for today's list of reporting companies.
Werbung